New Delhi: Two days after expressing “some preliminary good news” on the efficacy of Oxford vaccine candidate developed by the University of Oxford with AstraZeneca Plc, India’s Serum Institute CEO Adar Poonawalla told NDTV on Wednesday that the first batch of 100 million doses should be available by the second or third quarter of 2021.
“If we don’t go for an emergency license, our trials should be over by December and then we can maybe launch it in India in January subject to the UK trial also being completed,” he was quoted as saying by the news channel.
According to a Bloomberg article, Oxford COVID vaccine “has produced a robust immune response in older adults and the elderly, those at highest risk of severe illness.”
Berhampur: Hundreds of thalassemia and sickle cell patients on Tuesday staged a demonstration demanding a…
Mumbai: Actress Samantha Ruth Prabhu and her ex-husband actor Naga Chaitanya have moved on after…
Mumbai: Amidst rumours of their divorce, Bollywood queen Aishwarya Rai asked women to stand up…
Bhubaneswar: Prime Minister Narendra Modi will participate in a roadshow on his arrival at Bhubaneswar…
New York: Elon Musk, father of 12 children with different partners, has led an eventful…
Bhubaneswar: Vigilance has apprehended a college principal while taking a bribe of Rs 1 lakh…
Mumbai: Ahead of the release of Allu Arjun's highly-anticipated ‘Pushpa: The Rule’, one of the…
Bhubaneswar: The Odisha government has rejected the application of IAS officer Sujata R Karthikeyan for…